The effects ofBerberis vulgarisL. andBerberis aristataL. in metabolic syndrome patients: a systematic and meta-analysis study

Roshanravan B., Yousefizadeh S., Yildirim B., Farkhondeh T., Amirabadizadeh A., Ashrafizadeh M., ...Daha Fazla

ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1080/13813455.2020.1828482
  • Dergi Adı: ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, Chemical Abstracts Core, EMBASE, Food Science & Technology Abstracts, MEDLINE, Veterinary Science Database
  • Anahtar Kelimeler: Berberis aristataL, Berberis vulgarisL, metabolic syndrome, BERBERIS-ARISTATA/SILYBUM-MARIANUM, LIPID PROFILE, FIXED COMBINATION, DOUBLE-BLIND, ASSOCIATION, STATINS, AGENTS
  • Atatürk Üniversitesi Adresli: Evet

Özet

Introduction This meta-analysis study assessed the effects ofBerberis vulgarisL. andBerberis aristataL. in patients with metabolic syndrome Methods Data were analysed through "random-effects meta-regression" performance Results The findings indicated that LDL was 0.68 and 2.92 lower in theB. vulgarisL. andB. aristataL.-treated groups versus the controls. The HDL was 0.71-fold higher in theB. aristataL.-treated group versus the controls. The total-cholesterol levels were 1.02 and 2.25 folds lower in theB. vulgarisL. andB. aristataL.-treated groups versus the matched control groups. The triglyceride levels were 1.35 and 1.16-fold lower in theB. vulgarisL. andB. aristataL.-treated groups versus the controls. Glucose was 0.96 and 0.54 folds lower in theB. vulgarisL. andB. aristataL.-treated groups versus the control groups, respectively Conclusion B. vulgarisL. andB. aristataL. have beneficial effects in patients with metabolic syndrome.